Curcic, P; Herrmann, M; Pailer, S; Mangge, H; Benedikt, M; von Lewinski, D; Aziz, F; Kolesnik, E; Tripolt, NJ; Pferschy, P; Wallner, M; Zirlik, A; Sourij, H.
Impact of the SGLT2-inhibitor Empagliflozin on inflammatory biomarkers in acute coronary syndrome-a post-hoc analysis of the EMMY trial
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S361-S361.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science